[1]
|
Crous-Bou, M., Minguillon, C., Gramunt, N., et al. (2017) Alzheimer’s Disease Prevention: From Risk Factors to Early Intervention. Alzheimer’s Research & Therapy, 9, Article No. 71. https://doi.org/10.1186/s13195-017-0297-z
|
[2]
|
Jia, L., Du, Y., Chu, L., et al. (2020) Prevalence, Risk Factors, and Management of Dementia and Mild Cognitive Impairment in Adults Aged 60 Years or Older in China: A Cross-Sectional Study. The Lancet Public Health, 5, e661-e671.
https://doi.org/10.1016/S2468-2667(20)30185-7
|
[3]
|
Schneider, L., Thomas, R., Hendrix, S., et al. (2019) Safety and Efficacy of Edonerpic Maleate for Patients with Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clini-cal Trial. JAMA Neurology, 76, 1330-1339.
https://doi.org/10.1001/jamaneurol.2019.1868
|
[4]
|
Kitamura, S., Nakamura, Y., Homma, A., et al. (2014) Tolera-bility and Efficacy of the Long-Term Administration of Memantine Hydrochloride (Memary®) in Patients with Moderate to Severe Alzheimer’s Disease. Nihon Ronen Igakkai Zasshi Japanese Journal of Geriatrics, 51, 74-84. https://doi.org/10.3143/geriatrics.51.74
|
[5]
|
Sevigny, J., Chiao, P., Bussière, T., et al. (2017) Addendum: The An-tibody Aducanumab Reduces Aβ Plaques in Alzheimer’s Disease. Nature, 546, 564. https://doi.org/10.1038/nature22809
|
[6]
|
李筱筱, 武雪玲, 张凯, 等. 丹参酮II A对阿尔兹海默病防治作用的研究进展[J]. 生命科学研究, 2017, 21(1): 59-63.
|
[7]
|
庞伟, 周琛, 陈艳. 多奈哌齐联合红景天治疗阿尔茨海默病临床疗效评价[J]. 中国医药科学, 2017, 7(7): 59-61.
|
[8]
|
李爱东, 陈建良, 夏军, 等. 三七总皂苷治疗阿尔茨海默病的多中心随机对照临床研究[J]. 老年医学与保健, 2019, 25(4): 501-505.
|
[9]
|
Shi, X., Zhang, H., Zhou, Z., et al. (2018) Effects of Safflower Yellow on Beta-Amyloid Deposition and Activation of Astrocytes in the Brain of APP/PS1 Transgenic Mice. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 98, 553-565. https://doi.org/10.1016/j.biopha.2017.12.099
|
[10]
|
张为, 胡才友, 吕渊, 等. 复方丹参片联合多奈哌齐治疗阿尔茨海默病的临床疗效研究[J]. 中国现代医学杂志, 2018, 28(25): 37-40.
|
[11]
|
Hua, Q., Qing, X., Li, P., et al. (2010) Brain Microvascular Endothelial Cells Mediate Neuroprotective Effects on Ischemia/Reperfusion Neurons. Journal of Ethnopharmacology, 129, 306-313.
https://doi.org/10.1016/j.jep.2010.03.024
|
[12]
|
董晓红, 贾佩华, 张正一, 等. 补阳还五汤对AD模型小鼠血脑屏障及MMP-2、MMP-9的影响[J]. 中医药学报, 2020, 48(12): 12-16.
|
[13]
|
于修芳, 雷霞, 曹玲, 等. 补阳还五汤对阿尔茨海默病小鼠海马凋亡因子及学习记忆能力的影响[J]. 中国实验方剂学杂志, 2018, 24(3): 109-113.
|
[14]
|
周志昆, 曾红兵, 陈超. 黄芪三仙汤通过海马神经肽Y调节细胞免疫功能的实验研究[J]. 安徽中医学院学报, 2005, 24(4): 37-39.
|
[15]
|
杨林, 谭玉玲. 中药红芪研究现状[J]. 中外医疗, 2010, 29(5): 120-121.
|
[16]
|
Lin, Z., Gu, J., Xiu, J., et al. (2012) Traditional Chinese Medicine for Senile Dementia. Evidence-Based Complementary and Alternative Medicine, 2012, Article ID: 692621. https://doi.org/10.1155/2012/692621
|
[17]
|
Liu, P., Kong, M., Yuan, S., et al. (2014) History and Experience: A Survey of Traditional Chinese Medicine Treatment for Alzheimer’s Disease. Evi-dence-Based Complementary and Alternative Medicine, 2014, Article ID: 642128.
https://doi.org/10.1155/2014/642128
|
[18]
|
Li, J., Wu, H., Zhou, R., et al. (2008) Huperzine A for Alzheimer’s Dis-ease. The Cochrane Database of Systematic Reviews, No. 2, CD005592. https://doi.org/10.1002/14651858.CD005592.pub2
|
[19]
|
Su, Y., Wang, Q., Wang, C., et al. (2014) The Treatment of Alzheimer’s Disease Using Chinese Medicinal Plants: From Disease Models to Potential Clinical Applications. Jour-nal of Ethnopharmacology, 152, 403-423.
https://doi.org/10.1016/j.jep.2013.12.053
|
[20]
|
Cheung, T.S., Song, T.H., Ng, T.B., et al. (2015) Therapeutic Ef-fects of Herbal Chemicals in Traditional Chinese Medicine on Alzheimer’s Disease. Current Medicinal Chemistry, 22, 2392-2403.
https://doi.org/10.2174/0929867322666150520095509
|
[21]
|
Gao, J., Inagaki, Y., Li, X., et al. (2013) Research Progress on Natural Products from Traditional Chinese Medicine in Treatment of Alzheimer’s Disease. Drug Discoveries & Therapeutics, 7, 46-57.
|
[22]
|
Gao, J., Inagaki, Y. and Liu, Y. (2013) Research Progress on Flavonoids Isolated from Traditional Chinese Medicine in Treatment of Alzheimer’s Disease. Intractable & Rare Diseases Research, 2, 3-10.
https://doi.org/10.5582/irdr.2013.v2.1.3
|
[23]
|
Pan, H.-D., Xiao, Y., Wang, W.-Y., et al. (2019) Traditional Chinese Medicine as a Treatment for Rheumatoid Arthritis: From Empirical Practice to Evidence-Based Therapy. Engineering, 5, 895-906.
https://doi.org/10.1016/j.eng.2019.01.018
|
[24]
|
Nabavi, S.F., Braidy, N., Orhan, I.E., et al. (2016) Rhodiola rosea L. and Alzheimer’s Disease: From Farm to Pharmacy. Phytotherapy Research, 30, 532-539. https://doi.org/10.1002/ptr.5569
|
[25]
|
Shi, J.M., He, X., Lian, H.J., et al. (2015) Tibetan Medicine “RNSP” in Treatment of Alzheimer Disease. International Journal of Clinical and Experimental Medicine, 8, 19874-19880.
|
[26]
|
王丽. 藏药柳茶提取物对阿尔茨海默病大鼠治疗效应的观察及作用机制的蛋白质组学研究[D]: [硕士学位论文]. 兰州: 兰州大学, 2014.
|
[27]
|
周雅楠. 藏药旺拉提取物CE对Aβ25-35介导的大鼠神经元毒性损伤作用的研究[D]: [硕士学位论文]. 北京: 中央民族大学, 2012.
|
[28]
|
田诗琪, 赵慧源, 张帆, 等. 红景天苷对东莨菪碱诱导阿尔茨海默病模型大鼠炎症因子的影响[J]. 实用临床医药杂志, 2022, 26(1): 26-30.
|
[29]
|
Buriani, A., Garcia-Bermejo, M.L., Bosisio, E., et al. (2012) Omic Techniques in Systems Biology Approaches to Traditional Chinese Medicine Re-search: Present and Future. Journal of Ethnopharmacology, 140, 535-544.
https://doi.org/10.1016/j.jep.2012.01.055
|
[30]
|
Liu, Y., Ai, N., Liao, J., et al. (2015) Transcriptomics: A Sword to Cut the Gordian Knot of Traditional Chinese Medicine. Biomarkers in Medicine, 9, 1201-1213. https://doi.org/10.2217/bmm.15.91
|
[31]
|
Sulistio, Y.A. and Heese, K. (2015) Proteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer’s Disease. Evidence-Based Complementary and Alternative Medicine, 2015, Article ID: 393510.
https://doi.org/10.1155/2015/393510
|
[32]
|
Xu, Q., Bauer, R., Hendry, B.M., et al. (2013) The Quest for Moderni-sation of Traditional Chinese Medicine. BMC Complementary and Alternative Medicine, 13, Article No. 132. https://doi.org/10.1186/1472-6882-13-132
|